These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12846372)

  • 1. The Norwegian Breast Cancer Screening Program: re-attendance related to the women's experiences, intentions and previous screening result.
    Hofvind SS; Wang H; Thoresen S
    Cancer Causes Control; 2003 May; 14(4):391-8. PubMed ID: 12846372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of compression force and pressure at prevalent screening on subsequent re-attendance in a national screening program.
    Moshina N; Sebuødegård S; Holen ÅS; Waade GG; Tsuruda K; Hofvind S
    Prev Med; 2018 Mar; 108():129-136. PubMed ID: 29337068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting women's response to an invitation to attend for a second breast cancer screening examination.
    Orton M; Fitzpatrick R; Fuller A; Mant D; Mlynek C; Thorogood M
    Br J Gen Pract; 1991 Aug; 41(349):320-2. PubMed ID: 1777275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.
    Brett J; Austoker J
    J Public Health Med; 2001 Dec; 23(4):292-300. PubMed ID: 11873891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Attendance in the Norwegian Breast Cancer Screening Programme].
    Sebuødegård S; Sagstad S; Hofvind S
    Tidsskr Nor Laegeforen; 2016 Sep; 136(17):1448-51. PubMed ID: 27686204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of predictors of attendance for breast screening in inner London.
    Sutton S; Bickler G; Sancho-Aldridge J; Saidi G
    J Epidemiol Community Health; 1994 Feb; 48(1):65-73. PubMed ID: 8138773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme.
    Bhargava S; Tsuruda K; Moen K; Bukholm I; Hofvind S
    J Med Screen; 2018 Sep; 25(3):155-161. PubMed ID: 29059006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
    Duijm LE; Guit GL; Zaat JO
    Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring women's experiences during three rounds of breast cancer screening: results from a longitudinal study.
    Drossaert CH; Boer H; Seydel ER
    J Med Screen; 2002; 9(4):168-75. PubMed ID: 12518007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited.
    Gram IT; Slenker SE
    Am J Public Health; 1992 Feb; 82(2):249-51. PubMed ID: 1739156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study.
    Lund E; Mode N; Waaseth M; Thalabard JC
    BMC Cancer; 2013 Dec; 13():614. PubMed ID: 24377727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting reattendance to the second round of the Maltese national breast screening programme: an analytical descriptive study.
    Marmarà D; Marmarà V; Hubbard G
    BMC Public Health; 2019 Feb; 19(1):189. PubMed ID: 30760275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of false positive breast screening examinations on subsequent attendance: retrospective cohort study.
    Maxwell AJ; Beattie C; Lavelle J; Lyburn I; Sinnatamby R; Garnett S; Herbert A
    J Med Screen; 2013 Jun; 20(2):91-8. PubMed ID: 24009091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of false-positive results on reattendance at breast cancer screening programmes in Spain.
    Alamo-Junquera D; Murta-Nascimento C; Macià F; Baré M; Galcerán J; Ascunce N; Zubizarreta R; Salas D; Román R; Castells X; Sala M;
    Eur J Public Health; 2012 Jun; 22(3):404-8. PubMed ID: 21558152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Flemish women in semi-rural areas be motivated to attend organized breast cancer screening?
    Van Hal G; Matthyssen M; Thibaut A; Weyler J
    Rev Epidemiol Sante Publique; 1999 Apr; 47(2):119-27. PubMed ID: 10367299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program.
    Hofvind S; Geller B; Vacek PM; Thoresen S; Skaane P
    Eur J Epidemiol; 2007; 22(7):447-55. PubMed ID: 17594526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.
    Otten JD; van Dijck JA; Peer PG; Straatman H; Verbeek AL; Mravunac M; Hendriks JH; Holland R
    J Epidemiol Community Health; 1996 Jun; 50(3):353-8. PubMed ID: 8935470
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.